With its immune-nourishing glycoproteins, biotech company Helaina is the first company to bring the immunity properties of breast milk to food for all stages of life – bridging the gap between food and medicine.

Ahead of Future Food-Tech next month, Callum Alexander-Lindsay sat down with Laura Katz, CEO to find out about infant nutrition, the dual focus for the company, and scaling.

Helaina’s Chief Technology Officer, Anthony Clark joins the ‘Food as Medicine: Innovation to Address Consumer Health’ panel in San Francisco on March 16-17.